Diagnostic criteria for the classification of cancer-associated weight loss

Journal of Clinical Oncology

Volumn 33, Issue 1, 2015, Pages 90-99

  Martin, Lisa ^a   Senesse, Pierre ^d   Gioulbasanis, Ioannis ^f   Antoun, Sami ^e   Bozzetti, Federico ^g   Deans, Chris ^c   Strasser, Florian ⁱ   Thoresen, Lene ^j   Jagoe, R Thomas ^b   Chasen, Martin ^c   Lundholm, Kent ^k   Bosaeus, Ingvar ^l   Fearon, Kenneth H ^h   Baracos, Vickie E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d CENTRE VAL D AURELLE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f Larissa General Clinic   (Greece)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^j TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^k UNIVERSITY OF GOTHENBURG   (Sweden)

^l SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CANCER ASSOCIATED WEIGHT LOSS; CANCER LOCALIZATION; CANCER STAGING; CIRCADIAN RHYTHM; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; OVERALL SURVIVAL; PROSPECTIVE STUDY; SURVIVAL PREDICTION; SURVIVAL TIME; UNDERWEIGHT; WEIGHT GAIN; WEIGHT REDUCTION; CACHEXIA; CANADA; CLASSIFICATION; COMPLICATION; EUROPE; FACTUAL DATABASE; HEALTH SURVEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL;

AGED; BODY MASS INDEX; CACHEXIA; CANADA; DATABASES, FACTUAL; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WEIGHT LOSS;

EID: 84920623715     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.1894     Document Type: Article

References (35)

1. Dewys WD, Begg C, Lavin P.T., et al: Prognostic effect of weight loss prior to chemotherapy in cancer patients: Eastern Cooperative Oncology Group. Am J Med 69:491-497, 1980
2. US Department of Health and Human Services, National Institute of Health, National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm#ctc-40
3. Blum D, Omlin A, Baracos V.E., et al: Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80:114-144, 2011
4. Spiro A, Baldwin C, Patterson A., et al: The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95:431-434, 2006
5. Jensen GL, Hsiao PY, Wheeler D: Adult nutrition assessment tutorial. JPEN J Parenter Enteral Nutr 36:267-274, 2012
6. Nguyen DM, El-Serag HB: The epidemiology of obesity. Gastroenterol Clin North Am 39:1-7, 2010
7. Tao W, Lagergren J: Clinical management of obese patients with cancer. Nat Rev Clin Oncol 10:519-533, 2013
8. Fearon K, Arends J, Baracos V: Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10:90-99, 2013
9. Flegal KM, Kit BK, Orpana H, et al: Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 309:71-82, 2013
10. Kalantar-Zadeh K., Horwich TB, Oreopoulos A, et al: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10:433-442, 2007
11. Li L, Kalantar-Zadeh K: Obesity that makes kidney cancer more likely but helps fight it more strongly. J Natl Cancer Inst 105:1848-1849, 2013
12. Fearon K, Strasser F, Anker S.D., et al: Definition and classification of cancer cachexia: An international consensus framework. Lancet Oncol 12: 489-495, 2010
13. Aapro M, Arends J, Bozzetti F., et al: Early recognition of malnutrition and cachexia in the cancer patient: A position paper of a European School of Oncology Task Force. Ann Oncol 25:1492-1499, 2014
14. Martin L, Watanabe S, Fainsinger R., et al: Prognostic factors in patients with advanced cancer: Use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28: 4376-4383, 2010
15. Martin L, Birdsell L, MacDonald N., et al: Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539-1547, 2013
16. Parmar MP, Swanson T, Jagoe RT: Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team. Support Care Cancer 21:2049-2057, 2013
17. Thoresen L, Fjeldstad I, Krogstad K., et al: Nutritional status of patients with advanced cancer: The value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16:33-42, 2002
18. Thoresen L, Frykholm G, Lydersen S., et al: The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl) 21:505-516, 2012
19. Gagnon B, Agulnik JS, Gioulbasanis I, et al: Montreal prognostic score: Estimating survival of patients with non-small cell lung cancer using clinical biomarkers. Br J Cancer 109:2066-2071, 2013
20. Gioulbasanis I, Georgoulias P, Vlachostergios P.J., et al: Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis. Lung Cancer 74:516-520, 2011
21. Bozzetti F, Mariani L, Lo V.S., et al: The nutritional risk in oncology: A study of 1, 453 cancer outpatients. Support Care Cancer 20:1919-1928, 2012
22. Chasen MR, Feldstain A, Gravelle D., et al: An interprofessional palliative care oncology rehabilitation program: Effects on function and predictors of program completion. Curr Oncol 20:301-309, 2013
23. Deans DA, Tan BH, Wigmore S.J., et al: The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100:63-69, 2009
24. Strasser F, Lutz TA, Maeder M.T., et al: Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: A randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 98:300-308, 2008
25. Fearon KC, Von Meyenfeldt MF, Moses AG, et al: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. Gut 52:1479-1486, 2003
26. Fearon KC, Barber MD, Moses A.G., et al: Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24:3401-3407, 2006
27. Wallengren O, Bosaeus I, Lundholm K: Dietary energy density, inflammation and energy balance in palliative care cancer patients. Clin Nutr 32:88-92, 2013
28. Haverkort EB, de Haan RJ, Binnekade JM, et al: Self-reporting of height and weight: Valid and reliable identification of malnutrition in preoperative patients. Am J Surg 203:700-707, 2012
29. Perry GS, Byers TE, Mokdad A.H., et al: The validity of self-reports of past body weights by U.S. adults. Epidemiology 6:61-66, 1995
30. Blainey S: Consultation and clinical history-taking skills, in Ranson M, Abbott H, Braithwaite W (eds): Clinical Examination Skills for Health Professionals. Keswick, United Kingdom, M & K Update, 2014, pp 1-19
31. Ma C, Bandukwala S, Burman D., et al: Interconversion of three measures of performance status: An empirical analysis. Eur J Cancer 46:3175-3183, 2010
32. Harrell FE J.r., Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
33. Pencina MJ, D'Agostino RB: Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23:2109-2123, 2004
34. Kubrak C, Olson K, Jha N., et al: Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: A prospective longitudinal view. Head Neck 35:695-703, 2013
35. Prado CM, Lieffers JR, McCargar L.J., et al: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 9:629-635, 2008